Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective.

Mirre ScholteBram RamaekersEvangelos DanopoulosSabine E GrimmAndrea Fernandez CovesXiaoyu TianThomas DebrayJiongyu ChenLisa StirkRachel CroftManuela JooreNigel Armstrong

Published in: PharmacoEconomics (2024)

Keyphrases

type diabetes
cardiovascular disease
insulin resistance
glycemic control
adipose tissue
clinical evaluation